Newsletter Tool

To view this email as a web page, click here

Today's Rundown

CDC director: COVID-19 morphing into ‘pandemic of the unvaccinated’ as cases spike by 70%
Regeneron plans $1.8B upgrade at Tarrytown campus, where it aims to add 1,000 new staffers over 5 years
COVID-19 tracker: Pfizer's jab trumps Sinovac in new study; J&J doses to arrive in Africa
Fierce Pharma Asia—Sinovac, Sinopharm to supply 500M vaccine doses to COVAX; 2 approvals for Seagen-Astellas' Padcev
CMS launches all-out effort to boost ACA signups before special enrollment period ends

Featured Story

CDC director: COVID-19 morphing into ‘pandemic of the unvaccinated’ as cases spike by 70%

By Robert King

COVID-19 cases are up nearly 70% and reaching 30,000 infections per day primarily due to low vaccination rates in some parts of the country, according to the CDC.

Regeneron plans $1.8B upgrade at Tarrytown campus, where it aims to add 1,000 new staffers over 5 years

By Fraiser Kansteiner

Regeneron laid plans for a six-year, $1.8 billion expansion at its existing Westchester County campus, according to the New York Governor’s office. The expansion will see the company grow its New York headcount by 1,000 over the next five years.

COVID-19 tracker: Pfizer's jab trumps Sinovac in new study; J&J doses to arrive in Africa

By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner

The vaccine from Pfizer and BioNTech produced an antibody response roughly 10 times greater than the shot from China's Sinovac, a new study found. African countries will receive their first shipment of donated U.S. doses in the coming days. And more.

Fierce Pharma Asia—Sinovac, Sinopharm to supply 500M vaccine doses to COVAX; 2 approvals for Seagen-Astellas' Padcev

By Kevin Dunleavy

Sinovac and Sinopharm will supply up to 500 million vaccine doses to the COVAX worldwide relief effort. Seagen-Astellas gained two FDA approvals for bladder cancer treatment Padcev. BGI Group and the Chinese military reportedly shared data on millions of pregnant women who have used BGI's genetic test. And more.

CMS launches all-out effort to boost ACA signups before special enrollment period ends